kivizidiale 40 de micrograme/ml + 5 mg/ml
pharmathen sa - croatia - combinatii (travoprostum+timololum) - pic. oft., sol. - 40micrograme/ml+5mg/ml - antiglaucomatoase si miotice agenti betablocanti
kivizidiale 40 de micrograme/ml+5 mg/ml
pharmathen sa - croatia - combinatii (travoprostum+timololum) - pic. oft., sol. - 40micrograme/ml+5mg/ml - antiglaucomatoase si miotice agenti betablocanti
elonva solutie injectabila in seringa preumpluta 100 mcg/0,5 ml
merck sharp&dohme limited - corifollitropinum alfa - solutie injectabila in seringa preumpluta - 100 mcg/0,5 ml
elonva solutie injectabila in seringa preumpluta 150 mcg/0,5 ml
merck sharp&dohme limited - corifollitropinum alfa - solutie injectabila in seringa preumpluta - 150 mcg/0,5 ml
vinorelbina teva 10 mg/ml
sindan pharma s.r.l. - romania - vinorelbinum - conc. pt. sol. perf. - 10mg/ml - alcaloizi din plante si alte produse naturale alcaloizi din vinca si analogi
kivizidiale 40 de micrograme/ml+5 mg/ml
pharmathen sa - croatia - combinatii (travoprostum+timololum) - pic. oft., sol. - 40micrograme/ml+5mg/ml - antiglaucomatoase si miotice agenti betablocanti
olumiant
eli lilly nederland b.v. - baricitinib - artrita, reumatoida - imunosupresoare - rheumatoid arthritisbaricitinib is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). olumiant poate fi utilizat ca monoterapie sau în asociere cu metotrexat. atopic dermatitisolumiant is indicated for the treatment of moderate to severe atopic dermatitis in adult and paediatric patients 2 years of age and older who are candidates for systemic therapy. alopecia areatabaricitinib is indicated for the treatment of severe alopecia areata in adult patients (see section 5. juvenile idiopathic arthritisbaricitinib is indicated for the treatment of active juvenile idiopathic arthritis in patients 2 years of age and older who have had an inadequate response or intolerance to one or more prior conventional synthetic or biologic dmards:- polyarticular juvenile idiopathic arthritis (polyarticular rheumatoid factor positive [rf+] or negative [rf-], extended oligoarticular),- enthesitis related arthritis, and- juvenile psoriatic arthritis. baricitinib may be used as monotherapy or in combination with methotrexate.
nitromint 0,4 mg/doza
egis pharmaceuticals p.l.c. - ungaria - nitroglycerinum - spray sublingual - 0,4mg/doza - vasodilatatoare uitlizate in afectiuni cardiace nitrati organici
daruph 111 mg
zentiva, k.s. - republica ceha - dasatinibum - compr. film. - 111mg - inhibitori de protein-kinaza
daruph 16 mg
zentiva, k.s. - republica ceha - dasatinibum - compr. film. - 16mg - inhibitori de protein-kinaza